UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

Leukemia, 2021-09, Vol.35 (9), p.2517-2525

2021

Volltextzugriff (PDF)

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients

Annals of oncology, 2018-04, Vol.29 (4), p.973-978

2018

Volltextzugriff (PDF)

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

Journal of hematology and oncology, 2016-03, Vol.9 (18), p.18-18, Article 18

2016

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

Annals of oncology, 2017-11, Vol.28 (11), p.2793-2798

2017

Volltextzugriff (PDF)

The prognostic impact of 17p ( ) deletion in 2272 adults with acute myeloid leukemia

Leukemia, 2009-04, Vol.23 (4), p.656-663

2009

Volltextzugriff (PDF)

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ

Oncogene, 2017-08, Vol.36 (32), p.4573-4584

2017

Volltextzugriff (PDF)

A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer

Cancer cell, 2011-07, Vol.20 (1), p.79-91

2011

Volltextzugriff (PDF)

Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial

The lancet oncology, 2012-02, Vol.13 (2), p.207-214

2012

Volltextzugriff (PDF)

UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome

Blood cancer journal (New York), 2023-05, Vol.13 (1), p.88-88, Article 88

2023

Volltextzugriff (PDF)

Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex

Oncogene, 2016-07, Vol.35 (29), p.3760-3770

2016

Volltextzugriff (PDF)

Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians

Annals of hematology, 2016-09, Vol.95 (9), p.1399-1410

2016

Volltextzugriff (PDF)

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Journal of hematology and oncology, 2022-09, Vol.15 (1), p.1-126, Article 126

2022

Volltextzugriff (PDF)

Global Proteomic and Methylome Analysis in Human Induced Pluripotent Stem Cells Reveals Overexpression of a Human TLR3 Affecting Proper Innate Immune Response Signaling

Stem cells (Dayton, Ohio), 2019-04, Vol.37 (4), p.476-488

2019

Volltextzugriff (PDF)

Complexes formed by mutant p53 and their roles in breast cancer

Breast cancer targets and therapy, 2018-01, Vol.10, p.101-112

2018

Volltextzugriff (PDF)

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial

Leukemia, 2011-03, Vol.25 (3), p.420-428

2011

Volltextzugriff (PDF)

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

Leukemia, 2015-05, Vol.29 (5), p.1060-1068

2015

Volltextzugriff (PDF)

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ

Oncogene, 2017-08, Vol.36 (32), p.4671-4672

2017

Volltextzugriff (PDF)

Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival

Leukemia research, 2011-05, Vol.35 (5), p.620-625

2011

Volltextzugriff (PDF)

Role of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protection

Oncogene, 2005-03, Vol.24 (10), p.1749-1766

2005

Volltextzugriff (PDF)

Wiring the oncogenic circuitry: Pin1 unleashes mutant p53

Oncotarget, 2011-09, Vol.2 (9), p.654-656

2011

Volltextzugriff (PDF)

Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (16), p.6550-6558

2008

Volltextzugriff (PDF)

Cooperation of p53 mutations with other oncogenic alterations in cancer

Sub-cellular biochemistry, 2014, Vol.85, p.41

2014

Volltextzugriff (PDF)

Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target

Oncogene, 2003-11, Vol.22 (54), p.8738-8748

2003

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

The prognostic impact of 17p ( ) deletion in 2272 adults with acute myeloid leukemia

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ

Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations - a registry based analysis

A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer

Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial

UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome

Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex

Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Global Proteomic and Methylome Analysis in Human Induced Pluripotent Stem Cells Reveals Overexpression of a Human TLR3 Affecting Proper Innate Immune Response Signaling

Complexes formed by mutant p53 and their roles in breast cancer

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ

Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival

Role of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protection

Wiring the oncogenic circuitry: Pin1 unleashes mutant p53

Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells

Cooperation of p53 mutations with other oncogenic alterations in cancer

Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target

Aktive Filter

Suchergebnisse filtern